Treatment of cutaneous and pulmonary sarcoidosis with thalidomide - PubMed (original) (raw)
Case Reports
Treatment of cutaneous and pulmonary sarcoidosis with thalidomide
M Carlesimo et al. J Am Acad Dermatol. 1995 May.
Abstract
Many therapeutic agents have been proposed for treatment of steroid-resistant sarcoidosis. Because administration of low doses of thalidomide has been successful in treating other inflammatory diseases, it was used in a patient with systemic sarcoidosis who was unresponsive to corticosteroids and in a patient with pulmonary sarcoidosis, in whom Kaposi's sarcoma developed after a course of corticosteroid therapy. Thalidomide, 200 mg/day for 2 weeks followed by 100 mg/day for 11 weeks, was given. This treatment was effective in both patients. No adverse reactions were observed. Thalidomide, 100 mg on alternate days, is still being administered. No relapse has occurred. Thalidomide, particularly because of its inhibition of the macrophage function, may be a useful alternative therapy in steroid-resistant cases. In addition, the correlation between the angiotensin-converting enzyme level and the clinical improvement observed in our patients suggests a direct parallel between angiotensin-converting enzyme and the activity of the granulomatous process.
Similar articles
- Thalidomide for improving cutaneous and pulmonary sarcoidosis in patients resistant or with contraindications to corticosteroids.
Fazzi P, Manni E, Cristofani R, Cei G, Piazza S, Calabrese R, Antonelli A, Siciliano G, Barachini P, Carpi A. Fazzi P, et al. Biomed Pharmacother. 2012 Jun;66(4):300-7. doi: 10.1016/j.biopha.2012.03.005. Epub 2012 Mar 22. Biomed Pharmacother. 2012. PMID: 22494798 Clinical Trial. - Treatment of cutaneous sarcoidosis with thalidomide.
Nguyen YT, Dupuy A, Cordoliani F, Vignon-Pennamen MD, Lebbé C, Morel P, Rybojad M. Nguyen YT, et al. J Am Acad Dermatol. 2004 Feb;50(2):235-41. doi: 10.1016/j.jaad.2003.07.006. J Am Acad Dermatol. 2004. PMID: 14726878 Clinical Trial. - Thalidomide for chronic sarcoidosis.
Baughman RP, Judson MA, Teirstein AS, Moller DR, Lower EE. Baughman RP, et al. Chest. 2002 Jul;122(1):227-32. doi: 10.1378/chest.122.1.227. Chest. 2002. PMID: 12114363 Clinical Trial. - Pharmacotherapeutic management of pulmonary sarcoidosis.
Fazzi P. Fazzi P. Am J Respir Med. 2003;2(4):311-20. doi: 10.1007/BF03256659. Am J Respir Med. 2003. PMID: 14719997 Review. - Extensive cutaneous sarcoidosis and coexistant Crohn disease with dual response to infliximab: case report and review of the literature.
Chung J, Rosenbach M. Chung J, et al. Dermatol Online J. 2014 Dec 14;21(3):13030/qt6m04m5s3. Dermatol Online J. 2014. PMID: 25780977 Review.
Cited by
- Sarcoidosis and Its Dermatological Manifestations: A Narrative Review.
Koneti J, Cherukuri SP, Gadde S, Kalluru R, Chikatimalla R, Dasaradhan T. Koneti J, et al. Cureus. 2022 Aug 16;14(8):e28053. doi: 10.7759/cureus.28053. eCollection 2022 Aug. Cureus. 2022. PMID: 36127956 Free PMC article. Review. - Recurrent ECSIT mutation encoding V140A triggers hyperinflammation and promotes hemophagocytic syndrome in extranodal NK/T cell lymphoma.
Wen H, Ma H, Cai Q, Lin S, Lei X, He B, Wu S, Wang Z, Gao Y, Liu W, Liu W, Tao Q, Long Z, Yan M, Li D, Kelley KW, Yang Y, Huang H, Liu Q. Wen H, et al. Nat Med. 2018 Feb;24(2):154-164. doi: 10.1038/nm.4456. Epub 2018 Jan 1. Nat Med. 2018. PMID: 29291352 - Thalidomide in dermatology: revisited.
Hassan I, Dorjay K, Anwar P. Hassan I, et al. Indian J Dermatol. 2015 Mar-Apr;60(2):213. doi: 10.4103/0019-5154.152580. Indian J Dermatol. 2015. PMID: 25814738 Free PMC article. - Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.
Zhang C, Zhang X, Ma L, Peng F, Huang J, Han H. Zhang C, et al. Endocrine. 2012 Apr;41(2):248-55. doi: 10.1007/s12020-012-9600-8. Epub 2012 Jan 12. Endocrine. 2012. PMID: 22237514 - Cytokine modulators in the treatment of sarcoidosis.
Bargagli E, Olivieri C, Rottoli P. Bargagli E, et al. Rheumatol Int. 2011 Dec;31(12):1539-44. doi: 10.1007/s00296-011-1969-9. Epub 2011 Jun 5. Rheumatol Int. 2011. PMID: 21644041 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical